(Total Views: 585)
Posted On: 12/23/2020 11:01:49 AM
Post# of 155064
Re: Boatbuilder #69393
Boat, to understand the negative "news" used by Sykes and his despicable crew, read the Chris Long piece mentioned earlier on the board:
Insert-tag-herehttps://emerginggrowth.com/buyersstrike-short-attack-ahead-of-nasdaq-uplisting/
Basically, the two prongs of their attack were picturing MM's surely pre-programmed sales as a negative prediction for the SP and a deliberate misreading of the PR's headline "FDA resumes EIND approval" -- the Sykesians claimed to see that the PR was attempting to bamboozle people into thinking the FDA had given approval for the drug, despite words like "resumes" and "EIND" in the headline.
Insert-tag-herehttps://emerginggrowth.com/buyersstrike-short-attack-ahead-of-nasdaq-uplisting/
Basically, the two prongs of their attack were picturing MM's surely pre-programmed sales as a negative prediction for the SP and a deliberate misreading of the PR's headline "FDA resumes EIND approval" -- the Sykesians claimed to see that the PR was attempting to bamboozle people into thinking the FDA had given approval for the drug, despite words like "resumes" and "EIND" in the headline.
(2)
(0)
